/Companies

Iconic Therapeutics

South San Francisco, US · Delaware corporation · 4 known investors

Find your way into Iconic Therapeutics

Sign up to see every warm intro you have to Iconic Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Iconic Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

KD
Kirk DornbushExecutive
WGWilliam Greene
William GreeneExecutiveWilliam Greene holds an M.D. and has held leadership roles spanning biotechnology research, clinical program management, global venture capital investment, and board positions at life sciences firms; he has served as CEO of two biotech startups from discovery through fundraising and exits.

Board

JK
Johan KordelBoard director
BR
Bruce RobertsonBoard director
TFTodd Foley
Todd FoleyBoard directorManaging Director at MPM BioImpact
PH
Peter HirthBoard director
JS
Jon SoderstromBoard director

Investors · 4

Reported raises · per SEC filings

Form D private placements

$79M disclosed across 4 rounds · 2014–2019

▶$13MraisedApr 2019 · 37 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bruce CohenDirector
  • Peter HirthDirector
  • Bruce RobertsonDirector
  • Julia GregoryDirector
  • Todd FoleyDirector
  • William GreeneExecutive Officer, Director
  • Kirk DornbushDirector
Offering amount
$16.3M
Amount sold
$13M
Proceeds to insiders
$500K
First sale
Apr 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.1MraisedJun 2018 · 36 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Julia GregoryDirector
  • Kirk DornbushDirector
  • Peter HirthDirector
  • Bruce RobertsonDirector
  • William GreeneExecutive Officer, Director
  • Todd FoleyDirector
Offering amount
$10.9M
Amount sold
$4.1M
Proceeds to insiders
$500K
First sale
Jun 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$48.6MraisedNov 2016 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Johan KordelDirector
  • Bruce RobertsonDirector
  • Todd FoleyDirector
  • Kirk DornbushExecutive Officer, Director
  • Peter HirthDirector
  • William GreeneExecutive Officer, Director
Offering amount
$48.6M
Amount sold
$48.6M
Proceeds to insiders
$500K
First sale
Dec 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$13.3MraisedApr 2014 · 40 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kirk DornbushExecutive Officer, Director
  • Todd FoleyDirector
  • Bruce RobertsonDirector
  • Johan KordelDirector
  • William GreeneExecutive Officer, Director
  • Jon SoderstromDirector
Offering amount
$24.3M
Amount sold
$13.3M
Proceeds to insiders
$216K
First sale
Apr 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Iconic Therapeutics went on to found or lead other companies.

Frequently asked questions

Who are Iconic Therapeutics's investors?
Iconic Therapeutics's investors include Elm Street Ventures, OUP (Osage University Partners), Xeraya Capital, MPM BioImpact.
How much funding has Iconic Therapeutics raised?
Iconic Therapeutics has disclosed $79M raised across 4 rounds.
Where is Iconic Therapeutics headquartered?
Iconic Therapeutics is headquartered in South San Francisco, US.